MKMichael Alan Kryger

Michael Alan Kryger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael Alan Kryger has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Effect of the Interactive Mobile Health and Rehabilitation System on Health and Psychosocial Outcomes in Spinal Cord Injury: Randomized Controlled Trial

    by Michael Alan Kryger, Theresa M Crytzer, Andrea Fairman, Eleanor J Quinby, Meredith Karavolis, Gede Pramana, I Made Agus Setiawan, Gina Pugliano McKernan, Bambang Parmanto, Brad E Dicianno

    Background: Individuals with spinal cord injury (SCI) are at risk for secondary medical complications, such as urinary tract infections (UTIs) and pressure injuries, that could potentially be mitigated through improved self-management techniques. The Interactive Mobile Health and Rehabilitation (iMHere) mobile health (mHealth) system was developed to support self-management for individuals with disabilities. Objective: The main objective of this study was to determine if the use of iMHere would be associated with improved health outcomes over a 9-month period. A secondary objective was to determine if the use of iMHere would be associated with improved psychosocial outcomes. Phone usage, app usage, and training time data were also collected to analyze trends in iMHere use. Methods: Overall, 38 participants with SCI were randomized into either the intervention group who used the iMHere system and received standard care or the control group who received standard care without any technology intervention. Health outcomes were recorded for the year before entry into the study and during the 9 months of the study. Participants completed surveys at baseline and every 3 months to measure psychosocial outcomes. Results: The intervention group had a statistically significant reduction in UTIs (0.47 events per person; P=.03; number needed to treat=2.11). Although no psychosocial outcomes changed significantly, there was a nonsignificant trend toward a reduction in mood symptoms in the intervention group compared with the control group meeting the threshold for clinical significance. Approximately 34 min per participant per month were needed on average to manage the system and provide technical support through this mHealth system. Conclusions: The use of the iMHere mHealth system may be a valuable tool in the prevention of UTIs or reductions in depressive symptoms. Given these findings, iMHere has potential scalability for larger populations. Trial Registration: ClinicalTrials.gov NCT02592291; https://clinicaltrials.gov/ct2/show/NCT02592291.


  • Open Access

    The Effect of the Interactive Mobile Health and Rehabilitation System on Health and Psychosocial Outcomes in Spinal Cord Injury: Randomized Controlled Trial (Preprint)

    by Michael Alan Kryger, Theresa M Crytzer, Andrea Fairman, Eleanor J Quinby, Meredith Karavolis, Gede Pramana, I Made Agus Setiawan, Gina Pugliano McKernan, Bambang Parmanto, Brad E Dicianno

    BACKGROUND Individuals with spinal cord injury (SCI) are at risk for secondary medical complications, such as urinary tract infections (UTIs) and pressure injuries, that could potentially be mitigated through improved self-management techniques. The Interactive Mobile Health and Rehabilitation (iMHere) mobile health (mHealth) system was developed to support self-management for individuals with disabilities. OBJECTIVE The main objective of this study was to determine if the use of iMHere would be associated with improved health outcomes over a 9-month period. A secondary objective was to determine if the use of iMHere would be associated with improved psychosocial outcomes. Phone usage, app usage, and training time data were also collected to analyze trends in iMHere use. METHODS Overall, 38 participants with SCI were randomized into either the intervention group who used the iMHere system and received standard care or the control group who received standard care without any technology intervention. Health outcomes were recorded for the year before entry into the study and during the 9 months of the study. Participants completed surveys at baseline and every 3 months to measure psychosocial outcomes. RESULTS The intervention group had a statistically significant reduction in UTIs (0.47 events per person; P=.03; number needed to treat=2.11). Although no psychosocial outcomes changed significantly, there was a nonsignificant trend toward a reduction in mood symptoms in the intervention group compared with the control group meeting the threshold for clinical significance. Approximately 34 min per participant per month were needed on average to manage the system and provide technical support through this mHealth system. CONCLUSIONS The use of the iMHere mHealth system may be a valuable tool in the prevention of UTIs or reductions in depressive symptoms. Given these findings, iMHere has potential scalability for larger populations. CLINICALTRIAL ClinicalTrials.gov NCT02592291; https://clinicaltrials.gov/ct2/show/NCT02592291.


  • Flight simulation using a Brain-Computer Interface: A pilot, pilot study

    by Michael Kryger, Brock Wester, Eric A. Pohlmeyer, Matthew Rich, Brendan John, James Beaty, Michael McLoughlin, Michael Boninger, Elizabeth C. Tyler-Kabara


  • Collaborative Approach in the Development of High‐Performance Brain–Computer Interfaces for a Neuroprosthetic Arm: Translation from Animal Models to Human Control

    by Jennifer L. Collinger, Michael A. Kryger, Richard Barbara, Timothy Betler, Kristen Bowsher, Elke H. P. Brown, Samuel T. Clanton, Alan D. Degenhart, Stephen T. Foldes, Robert A. Gaunt, et al.

    Our research group recently demonstrated that a person with tetraplegia could use a brain–computer interface (BCI) to control a sophisticated anthropomorphic robotic arm with skill and speed approaching that of an able‐bodied person. This multiyear study exemplifies important principles in translating research from foundational theory and animal experiments into a clinical study. We present a roadmap that may serve as an example for other areas of clinical device research as well as an update on study results. Prior to conducting a multiyear clinical trial, years of animal research preceded BCI testing in an epilepsy monitoring unit, and then in a short‐term (28 days) clinical investigation. Scientists and engineers developed the necessary robotic and surgical hardware, software environment, data analysis techniques, and training paradigms. Coordination among researchers, funding institutes, and regulatory bodies ensured that the study would provide valuable scientific information in a safe environment for the study participant. Finally, clinicians from neurosurgery, anesthesiology, physiatry, psychology, and occupational therapy all worked in a multidisciplinary team along with the other researchers to conduct a multiyear BCI clinical study. This teamwork and coordination can be used as a model for others attempting to translate basic science into real‐world clinical situations.


  • Open Access

    Pattern recognition control of multifunction myoelectric prostheses by patients with congenital transradial limb defects

    by Michael Kryger, Aimee E Schultz, Todd Kuiken

    Background: Electromyography (EMG) pattern recognition offers the potential for improved control of multifunction myoelectric prostheses. However, it is unclear whether this technology can be successfully used by congenital amputees. Objective: The purpose of this investigation was to assess the ability of congenital transradial amputees to control a virtual multifunction prosthesis using EMG pattern recognition and compare their performance to that of acquired amputees from a previous study. Study Design: Preliminary cross-sectional study. Methods: Four congenital transradial amputees trained and tested a linear discriminant analysis (LDA) classifier with four wrist movements, five hand movements, and a no-movement class. Subjects then tested the classifier in real time using a virtual arm. Results: Performance metrics for the residual limb were poorer than those with the intact limb (classification accuracy: 52.1%±15.0% vs. 93.2%±15.8%; motion-completion rate: 49.0%±23.0% vs. 84.0%±9.4%; motion-completion time: 2.05±0.75 s vs. 1.13±0.05 s, respectively). On average, performance with the residual limb by congenital amputees was reduced compared to that reported for acquired transradial amputees. However, one subject performed similarly to acquired amputees. Conclusions: Pattern recognition control may be a viable option for some congenital amputees. Further study is warranted to determine success factors.